January 2, 2019
March 30, 2023
August 20, 2024
Underground tunnels. That is where the conversation began between Twitter/X CEO Elon Musk and former President Donald Trump before moving to reforming the US Food and Drug Administration. Musk was discussing the impact of overregulation on drilling underground tunnels to alleviate traffic in congested cities when he deftly turned to another area that he believes…
Read MoreAugust 9, 2024
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), has been selected as the recipient of the 2024 Beacon Award for Women Leaders in Oncology in recognition of her tireless and innovative leadership in the fight against cancer. The Beacon Award for Women Leaders in Oncology was established…
Read MoreAugust 6, 2024
Retirements from the Food and Drug Administration are hardly shocking, especially in the wake of pandemic burnout. But when longtime medical device director Jeff Shuren announced his departure in July, the device world was stunned. Industry leaders, patient advocates, and FDA colleagues alike had grown accustomed to the ambitious, politically-savvy regulator. “It’s sort of hard to imagine…
Read MoreJuly 30, 2024
Lunit, a Korean medical AI imaging company, is reportedly close to securing a major commercialization contract with a multinational pharmaceutical company for its AI biomarker platform, Lunit SCOPE. The company confirmed that these negotiations are expected to be finalized by the end of the year. According to Lunit, Lunit SCOPE’s biomarker analysis services are currently being…
Read MoreJuly 26, 2024
What will happen to biomedical research and health care in the aftermath of the 2024 election? The differences in outcomes couldn’t be more stark. Vice President Kamala Harris, who became the Democratic frontrunner on July 21 after President Joe Biden announced his decision not to seek reelection, is expected to pursue a science agenda…
Read MoreJuly 19, 2024
NIH Director Monica Bertagnolli and Rep. for Kentucky’s 2nd congressional district, Brett Guthrie were named recipients of Friends of Cancer Research 2024 Cancer Leadership Award. Bertagnolli and Guthrie will be honored on Sept. 19, 2024, in Washington, DC. Monica Bertagnolli will receive the Ellen V. Sigal Advocacy Leadership Award, recognizing her incredible contributions to the…
Read MoreJuly 19, 2024
NIH Director Monica Bertagnolli and Rep. for Kentucky’s 2nd congressional district, Brett Guthrie were named recipients of Friends of Cancer Research 2024 Cancer Leadership Award. Bertagnolli and Guthrie will be honored on Sept. 19, 2024, in Washington, DC. Monica Bertagnolli will receive the Ellen V. Sigal Advocacy Leadership Award, recognizing her incredible contributions to the…
Read MoreJuly 9, 2024
Industry and researchers welcomed a set of guidances from the US Food and Drug Administration (FDA) that seek to expand eligibility criteria in oncology clinical trials, but they pushed for clearer examples of how to apply the proposed flexibility, especially in early-stage trials. In April 2024, FDA issued a set of three draft guidance documents…
Read MoreJuly 5, 2024
The Supreme Court last week upended one of the underpinnings of administrative law by weakening the authority of federal health agencies to rely on technical expertise as they regulate medical products, issue coverage decisions, and respond to public health crises. The court’s decision in two cases, Loper Bright Enterprises v. Raimondo and Relentless Inc. v.…
Read MoreJuly 2, 2024
For the 12th consecutive year, OncLive is honored to recognize oncology leaders whose innovations have contributed to immeasurable improvements in outcomes for countless patients with cancer. The 15 winners of the 2024 Giants of Cancer Care awards have made their mark with novel therapies and protocols across the spectrum of care. BREAST CANCER Joseph A.…
Read More
